ClinicalTrials.gov record
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
ClinicalTrials.gov ID: NCT01479621
Public ClinicalTrials.gov record NCT01479621. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fluticasone Propionate DPI Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Persistent Asthma Uncontrolled on Non-steroidal Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo- and open-label active controlled, parallel-group, multicenter, dose ranging study in male or female subjects ages 12 years and older with persistent asthma who are uncontrolled on non-steroidal therapy. The primary objective of this study is to evaluate the dose response, efficacy and safety of 4 different doses of fluticasone propionate delivered as Fluticasone Propionate DPI (Dry Powder Inhaler) when administered twice daily.
Study identification
- NCT ID
- NCT01479621
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 909 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2011
- Primary completion
- Jun 30, 2013
- Completion
- Jun 30, 2013
- Last update posted
- Jun 4, 2017
2012 – 2013
United States locations
- U.S. sites
- 129
- U.S. states
- 35
- U.S. cities
- 107
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 10165 | Homewood | Alabama | — | — |
| Teva Investigational Site 11142 | Goodyear | Arizona | — | — |
| Teva Investigational Site 10104 | Scottsdale | Arizona | — | — |
| Teva Investigational Site 11149 | Little Rock | Arkansas | — | — |
| Teva Investigational Site 10173 | Bakersfield | California | — | — |
| Teva Investigational Site 10163 | Costa Mesa | California | — | — |
| Teva Investigational Site 10156 | Encinitas | California | — | — |
| Teva Investigational Site 11101 | Fountain Valley | California | — | — |
| Teva Investigational Site 11111 | Fresno | California | — | — |
| Teva Investigational Site 10151 | Granada Hills | California | — | — |
| Teva Investigational Site 10157 | Huntington Beach | California | — | — |
| Teva Investigational Site 10176 | Huntington Beach | California | — | — |
| Teva Investigational Site 10147 | Long Beach | California | — | — |
| Teva Investigational Site 11110 | Napa | California | — | — |
| Teva Investigational Site 10136 | Newport Beach | California | — | — |
| Teva Investigational Site 11122 | North Hollywood | California | — | — |
| Teva Investigational Site 10140 | Orange | California | — | — |
| Teva Investigational Site 10197 | Palmdale | California | — | — |
| Teva Investigational Site 10185 | Redwood City | California | — | — |
| Teva Investigational Site 10143 | Riverside | California | — | — |
| Teva Investigational Site 11137 | Roseville | California | — | — |
| Teva Investigational Site 10130 | San Diego | California | — | — |
| Teva Investigational Site 10182 | San Diego | California | — | — |
| Teva Investigational Site 10179 | San Jose | California | — | — |
| Teva Investigational Site 10106 | Stockton | California | — | — |
| Teva Investigational Site 10129 | Walnut Creek | California | — | — |
| Teva Investigational Site 10145 | Centennial | Colorado | — | — |
| Teva Investigational Site 10172 | Colorado Springs | Colorado | — | — |
| Teva Investigational Site 10133 | Denver | Colorado | — | — |
| Teva Investigational Site 10154 | Denver | Colorado | — | — |
| Teva Investigational Site 11146 | Denver | Colorado | — | — |
| Teva Investigational Site 10128 | Wheat Ridge | Colorado | — | — |
| Teva Investigational Site 10196 | Waterbury | Connecticut | — | — |
| Teva Investigational Site 10191 | Boynton Beach | Florida | — | — |
| Teva Investigational Site 11127 | Brandon | Florida | — | — |
| Teva Investigational Site 11118 | Clearwater | Florida | — | — |
| Teva Investigational Site 11141 | Hialeah | Florida | — | — |
| Teva Investigational Site 11140 | Kissimmee | Florida | — | — |
| Teva Investigational Site 10137 | Miami | Florida | — | — |
| Teva Investigational Site 10153 | Miami | Florida | — | — |
| Teva Investigational Site 11120 | Miami | Florida | — | — |
| Teva Investigational Site 11128 | Miami | Florida | — | — |
| Teva Investigational Site 11132 | Miami | Florida | — | — |
| Teva Investigational Site 11145 | Miami | Florida | — | — |
| Teva Investigational Site 10171 | Ocala | Florida | — | — |
| Teva Investigational Site 10178 | Sarasota | Florida | — | — |
| Teva Investigational Site 11103 | South Miami | Florida | — | — |
| Teva Investigational Site 10161 | Tallahassee | Florida | — | — |
| Teva Investigational Site 10139 | Tampa | Florida | — | — |
| Teva Investigational Site 11114 | Albany | Georgia | — | — |
| Teva Investigational Site 10111 | Columbus | Georgia | — | — |
| Teva Investigational Site 11124 | Columbus | Georgia | — | — |
| Teva Investigational Site 10180 | Gainesville | Georgia | — | — |
| Teva Investigational Site 10168 | Lawrenceville | Georgia | — | — |
| Teva Investigational Site 11109 | Idaho Falls | Idaho | — | — |
| Teva Investigational Site 10116 | Meridian | Idaho | — | — |
| Teva Investigational Site 10127 | South Bend | Indiana | — | — |
| Teva Investigational Site 10184 | Iowa City | Iowa | — | — |
| Teva Investigational Site 10113 | Metairie | Louisiana | — | — |
| Teva Investigational Site 10164 | Bangor | Maine | — | — |
| Teva Investigational Site 10158 | Bethesda | Maryland | — | — |
| Teva Investigational Site 10110 | Largo | Maryland | — | — |
| Teva Investigational Site 10177 | Wheaton | Maryland | — | — |
| Teva Investigational Site 10138 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 10146 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 10131 | Minneapolis | Minnesota | — | — |
| Teva Investigational Site 10175 | St Louis | Missouri | — | — |
| Teva Investigational Site 10189 | St Louis | Missouri | — | — |
| Teva Investigational Site 11147 | St Louis | Missouri | — | — |
| Teva Investigational Site 10118 | Bellevue | Nebraska | — | — |
| Teva Investigational Site 10150 | Omaha | Nebraska | — | — |
| Teva Investigational Site 11144 | Omaha | Nebraska | — | — |
| Teva Investigational Site 11136 | Henderson | Nevada | — | — |
| Teva Investigational Site 10114 | Brick | New Jersey | — | — |
| Teva Investigational Site 10193 | Cherry Hill | New Jersey | — | — |
| Teva Investigational Site 10101 | Hillsborough | New Jersey | — | — |
| Teva Investigational Site 10155 | Skillman | New Jersey | — | — |
| Teva Investigational Site 10188 | West Orange | New Jersey | — | — |
| Teva Investigational Site 11113 | Albuquerque | New Mexico | — | — |
| Teva Investigational Site 10187 | Brooklyn | New York | — | — |
| Teva Investigational Site 10120 | New York | New York | — | — |
| Teva Investigational Site 10190 | Newburgh | New York | — | — |
| Teva Investigational Site 10167 | North Syracuse | New York | — | — |
| Teva Investigational Site 10112 | Rochester | New York | — | — |
| Teva Investigational Site 10105 | High Point | North Carolina | — | — |
| Teva Investigational Site 10122 | Raleigh | North Carolina | — | — |
| Teva Investigational Site 10194 | Canton | Ohio | — | — |
| Teva Investigational Site 10107 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 10123 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 10144 | Columbus | Ohio | — | — |
| Teva Investigational Site 11135 | Dayton | Ohio | — | — |
| Teva Investigational Site 11115 | Middleburg Heights | Ohio | — | — |
| Teva Investigational Site 10160 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 10174 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 10198 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 11108 | Ashland | Oregon | — | — |
| Teva Investigational Site 10132 | Eugene | Oregon | — | — |
| Teva Investigational Site 10135 | Medford | Oregon | — | — |
| Teva Investigational Site 10142 | Portland | Oregon | — | — |
| Teva Investigational Site 11104 | Normal Square | Pennsylvania | — | — |
| Teva Investigational Site 10183 | Philadelphia | Pennsylvania | — | — |
| Teva Investigational Site 10166 | Pittsburgh | Pennsylvania | — | — |
| Teva Investigational Site 10121 | Upland | Pennsylvania | — | — |
| Teva Investigational Site 11119 | East Providence | Rhode Island | — | — |
| Teva Investigational Site 10181 | Lincoln | Rhode Island | — | — |
| Teva Investigational Site 10162 | Providence | Rhode Island | — | — |
| Teva Investigational Site 10126 | Charleston | South Carolina | — | — |
| Teva Investigational Site 10149 | Charleston | South Carolina | — | — |
| Teva Investigational Site 10199 | Orangeburg | South Carolina | — | — |
| Teva Investigational Site 11131 | Spartanburg | South Carolina | — | — |
| Teva Investigational Site 10119 | Boerne | Texas | — | — |
| Teva Investigational Site 10141 | Dallas | Texas | — | — |
| Teva Investigational Site 10192 | Dallas | Texas | — | — |
| Teva Investigational Site 10148 | El Paso | Texas | — | — |
| Teva Investigational Site 10115 | San Antonio | Texas | — | — |
| Teva Investigational Site 11133 | San Antonio | Texas | — | — |
| Teva Investigational Site 11134 | San Antonio | Texas | — | — |
| Teva Investigational Site 10103 | Waco | Texas | — | — |
| Teva Investigational Site 11143 | Layton | Utah | — | — |
| Teva Investigational Site 10195 | Provo | Utah | — | — |
| Teva Investigational Site 10134 | South Burlington | Vermont | — | — |
| Teva Investigational Site 10159 | Burke | Virginia | — | — |
| Teva Investigational Site 10102 | Fairfax | Virginia | — | — |
| Teva Investigational Site 11105 | Manassas | Virginia | — | — |
| Teva Investigational Site 10108 | Richmond | Virginia | — | — |
| Teva Investigational Site 10124 | Spokane | Washington | — | — |
| Teva Investigational Site 11117 | Tacoma | Washington | — | — |
| Teva Investigational Site 11125 | Tacoma | Washington | — | — |
| Teva Investigational Site 10170 | Greenfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01479621, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2017 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01479621 live on ClinicalTrials.gov.